C. Dani
Research Subjects
Research Interests
C. Dani has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Firmino F. Rubaltelli
Department of Pediatrics - Division of Neonatology, Careggi University Hospital of Florence, Florence
8 shared publications - Giovanna Bertini
Division of Neonatology, Careggi University Hospital of Florence, 50134 Florence, Italy
6 shared publications G Bertini
Division of Neonatology Careggi University Hospital of Florence, Florence, Italy
5 shared publicationsM F Reali
Pediatrics - Division Neonatology, Careggi University Hospital of Florence, Florence
4 shared publicationsV Vangi
Department of Medical and Surgical Critical Care, University of Florence, Section of Neonatology, Florence, Italy
3 shared publicationsFf Rubaltelli
Division of Neonatology Careggi University Hospital of Florence, Florence, Italy
2 shared publications
Latest Publications
- 1 August 2005
- Published by Springer Nature in Pediatric Research
- Vol. 58 (2) , 373
107 Comparison of Oral and Intravenous Ibuprofen Treatment of PDA in VLBW Infants: A Randomized Clinical Trial
- 1 August 2005
- Published by Springer Nature in Pediatric Research
- Vol. 58 (2) , 373
107 Comparison of Oral and Intravenous Ibuprofen Treatment of PDA in VLBW Infants: A Randomized Clinical Trial
- 1 August 2005
- Published by Springer Nature in Pediatric Research
- Vol. 58 (2) , 367
77 Inhaled Nitric Oxide in Preterm Infants of less than 30 Weeks' Gestation with Respiratory Distress Syndrome
- 1 August 2005
- Published by Springer Nature in Pediatric Research
- Vol. 58 (2) , 367
77 Inhaled Nitric Oxide in Preterm Infants of less than 30 Weeks' Gestation with Respiratory Distress Syndrome
- 1 September 2004
- Published by Springer Nature in Pediatric Research
- Vol. 56 (3) , 473
57 Prophylactic Ibuprofen for The Prevention of Intraventricular Hemorrhage in Preterm Infants: A Multicenter Randomized Study
- 1 September 2004
- Published by Springer Nature in Pediatric Research
- Vol. 56 (3) , 473
57 Prophylactic Ibuprofen for The Prevention of Intraventricular Hemorrhage in Preterm Infants: A Multicenter Randomized Study
- Open Access
- 1 March 2003
- Published by BMJ in Archives of Disease in Childhood - Fetal and Neonatal Edition
- Vol. 88 (2) , F119-F123
Plasma bilirubin level and oxidative stress in preterm infants
Objective: To assess the hypothesis that changes in plasma total bilirubin levels (Btot) can influence the antioxidant system and oxidative stress in preterm infants. Methods: Twenty two healthy preterm infants who presented with visible non-haemolytic hyperbilirubinaemia were studied at the mean (SD) age of 3.7 (1.5) days. Btot, plasma total hydroperoxide concentration (TH), plasma protein SH group concentration, and total antioxidant capacity of the plasma (TAC) were measured at study entry and after 24 hours. Results: Btot did not correlate with TH, TAC, or protein SH group concentration, but a significant correlation was found between TH and TAC, TH and protein SH groups, and TAC and protein SH groups, both at study entry and after 24 hours. Conclusion: The decrease in plasma bilirubin was contemporary with an increase in plasma antioxidant capacity and decrease in oxidative stress in preterm infants. This may be the result of the pro-oxidant effect of haem oxygenase, mediated by iron release, which may outcompete the antioxidant properties of bilirubin.
- 1 March 2003
- Published by BMJ in Archives of Disease in Childhood - Fetal and Neonatal Edition
- Vol. 88 (2) , F119-F123
Open AccessPlasma bilirubin level and oxidative stress in preterm infants
Objective: To assess the hypothesis that changes in plasma total bilirubin levels (Btot) can influence the antioxidant system and oxidative stress in preterm infants. Methods: Twenty two healthy preterm infants who presented with visible non-haemolytic hyperbilirubinaemia were studied at the mean (SD) age of 3.7 (1.5) days. Btot, plasma total hydroperoxide concentration (TH), plasma protein SH group concentration, and total antioxidant capacity of the plasma (TAC) were measured at study entry and after 24 hours. Results: Btot did not correlate with TH, TAC, or protein SH group concentration, but a significant correlation was found between TH and TAC, TH and protein SH groups, and TAC and protein SH groups, both at study entry and after 24 hours. Conclusion: The decrease in plasma bilirubin was contemporary with an increase in plasma antioxidant capacity and decrease in oxidative stress in preterm infants. This may be the result of the pro-oxidant effect of haem oxygenase, mediated by iron release, which may outcompete the antioxidant properties of bilirubin.
- 1 January 2000
- Published by Wiley in Acta Paediatrica
- Vol. 89 (11) , 1369-1374
Prophylaxis of patent ductus arteriosus with ibuprofen in preterm infants
The aim of our study was to evaluate whether the prophylactic use of ibuprofen would reduce the incidence of significant patent ductus arteriosus (PDA) and to confirm the effectiveness of ibuprofen as rescue treatment in closing PDA. Eighty preterm infants with gestational age less than 34 wk with infant respiratory distress syndrome (iRDS) were randomized to receive intravenous ibuprofen lysine (10 mg/kg, followed by 5 mg/kg after 24 and 48 h) either within 24 h of life (group A) or after echocardiographic diagnosis of PDA (group B). To evaluate the severity of RDS in each patient, we calculated the initial and highest values of Oxygenation Index (O.I. =mean airway pressure × FiO2 × 100 / PaO2) and Ventilatory Index (V.I. = O.I. × mechanical respiratory rate). Other studied variables were ventilatory support, renal function, biochemical and haematological profiles, frequency of bronchopulmonary dysplasia (BPD), intraventricular haemorrhage (IVH), necrotizing enterocolitis (NEC) and retinopathy of prematurity (ROP). On the 3rd day of life, 8% (3/40) of patients of group A and 53% of patients (21/40) of group B (p < 0.0001) developed a significant PDA. Between patients of group B who presented PDA at 3 d of life 90% (19/21) had a closure of ductus arteriosus after ibuprofen treatment. Initial and highest values of O.I. and V.I. were similar in both groups A and B. No significant differences between the groups were observed in regard to respiratory support, renal function and frequency of BPD, IVH, NEC and ROP. Ibuprofen was not associated with adverse effects. Conclusion: Prophylactic treatment with ibuprofen reduces PDA occurrence in preterm infants with iRDS at 3 d of life in comparison with rescue treatment, but both modes are effective in closing the ductus without significant adverse effects.
- 1 January 2000
- Published by Wiley in Acta Paediatrica
- Vol. 89 (11) , 1369-1374
Prophylaxis of patent ductus arteriosus with ibuprofen in preterm infants
The aim of our study was to evaluate whether the prophylactic use of ibuprofen would reduce the incidence of significant patent ductus arteriosus (PDA) and to confirm the effectiveness of ibuprofen as rescue treatment in closing PDA. Eighty preterm infants with gestational age less than 34 wk with infant respiratory distress syndrome (iRDS) were randomized to receive intravenous ibuprofen lysine (10 mg/kg, followed by 5 mg/kg after 24 and 48 h) either within 24 h of life (group A) or after echocardiographic diagnosis of PDA (group B). To evaluate the severity of RDS in each patient, we calculated the initial and highest values of Oxygenation Index (O.I. =mean airway pressure × FiO2 × 100 / PaO2) and Ventilatory Index (V.I. = O.I. × mechanical respiratory rate). Other studied variables were ventilatory support, renal function, biochemical and haematological profiles, frequency of bronchopulmonary dysplasia (BPD), intraventricular haemorrhage (IVH), necrotizing enterocolitis (NEC) and retinopathy of prematurity (ROP). On the 3rd day of life, 8% (3/40) of patients of group A and 53% of patients (21/40) of group B (p < 0.0001) developed a significant PDA. Between patients of group B who presented PDA at 3 d of life 90% (19/21) had a closure of ductus arteriosus after ibuprofen treatment. Initial and highest values of O.I. and V.I. were similar in both groups A and B. No significant differences between the groups were observed in regard to respiratory support, renal function and frequency of BPD, IVH, NEC and ROP. Ibuprofen was not associated with adverse effects. Conclusion: Prophylactic treatment with ibuprofen reduces PDA occurrence in preterm infants with iRDS at 3 d of life in comparison with rescue treatment, but both modes are effective in closing the ductus without significant adverse effects.
- 1 April 1999
- Published by Springer Nature in Pediatric Research
- Vol. 45 (4, Part 2 ) , 193A
Retinopathy of Prematurity in Infants with Birthweight Lower Than 1250 Grams: Role of Blood Transfusion, Iron and Erythropoietin Treatment
- 1 April 1999
- Published by Springer Nature in Pediatric Research
- Vol. 45 (4, Part 2 ) , 193A
Retinopathy of Prematurity in Infants with Birthweight Lower Than 1250 Grams: Role of Blood Transfusion, Iron and Erythropoietin Treatment
- 1 April 1999
- Published by Springer Nature in Pediatric Research
- Vol. 45 (4, Part 2 ) , 192A
Effects of Application of Vitamin E Ointment to Premature Neonates' Skin: Preliminary Data
- 1 April 1999
- Published by Springer Nature in Pediatric Research
- Vol. 45 (4, Part 2 ) , 192A
Effects of Application of Vitamin E Ointment to Premature Neonates' Skin: Preliminary Data
- 1 April 1999
- Published by Springer Nature in Pediatric Research
- Vol. 45 (4, Part 2 ) , 192A
Brain Hemodynamic Changes in Preterm Infants after Caffeine and Theophylline Treatment
- 1 April 1999
- Published by Springer Nature in Pediatric Research
- Vol. 45 (4, Part 2 ) , 192A
Brain Hemodynamic Changes in Preterm Infants after Caffeine and Theophylline Treatment
- 11 December 1998
- Published by Wiley in Acta Paediatrica
- Vol. 87 (12) , 1261-1268
Acute neonatal respiratory distress in Italy: a one-year prospective study
A prospective multicentre 12‐month survey of neonatal respiratory disorders in 63 537 Italian infants was performed to evaluate the incidence of acute neonatal respiratory disorders and of the main related complications. A total of 1427 developed respiratory disorders (2.2%), 208 of whom died (14.6%). The incidence of respiratory distress syndrome was 1.16%, with a case fatality rate (CFR) of 24%; that of transient tachypnoea was 0.93%, with a CFR of 1.3%. The rates of meconium aspiration syndrome, persistent pulmonary hypertension and pneumonia were 0.06%, 0.02% and 0.07%, with CFRs of 10.3%, 38.5% and 21.7%, respectively. The occurrences of the main complications in affected newborns were: bronchopulmonary dysplasia 5.6%, necrotizing enterocolitis 1.7%, patent ductus arteriosus 9.8%, 3o and 4o grade intraventricular haemorrhage 6.8% and air leak 4.9%. It was concluded that the incidence of acute neonatal respiratory disorders and the main related complications was lower than that reported two decades ago and that the CFR of acute neonatal respiratory disorders had increased. These results may be the consequences of (i) progress in the management of high‐risk pregnancies, (ii) an increased number of viable infants with extremely low birth weight and (iii) diffusion of antenatal treatment with corticosteroids which, in this series, seemed to reduce the morbidity but not the mortality in the high‐risk infants.
- 11 December 1998
- Published by Wiley in Acta Paediatrica
- Vol. 87 (12) , 1261-1268
Acute neonatal respiratory distress in Italy: a one-year prospective study
A prospective multicentre 12‐month survey of neonatal respiratory disorders in 63 537 Italian infants was performed to evaluate the incidence of acute neonatal respiratory disorders and of the main related complications. A total of 1427 developed respiratory disorders (2.2%), 208 of whom died (14.6%). The incidence of respiratory distress syndrome was 1.16%, with a case fatality rate (CFR) of 24%; that of transient tachypnoea was 0.93%, with a CFR of 1.3%. The rates of meconium aspiration syndrome, persistent pulmonary hypertension and pneumonia were 0.06%, 0.02% and 0.07%, with CFRs of 10.3%, 38.5% and 21.7%, respectively. The occurrences of the main complications in affected newborns were: bronchopulmonary dysplasia 5.6%, necrotizing enterocolitis 1.7%, patent ductus arteriosus 9.8%, 3o and 4o grade intraventricular haemorrhage 6.8% and air leak 4.9%. It was concluded that the incidence of acute neonatal respiratory disorders and the main related complications was lower than that reported two decades ago and that the CFR of acute neonatal respiratory disorders had increased. These results may be the consequences of (i) progress in the management of high‐risk pregnancies, (ii) an increased number of viable infants with extremely low birth weight and (iii) diffusion of antenatal treatment with corticosteroids which, in this series, seemed to reduce the morbidity but not the mortality in the high‐risk infants.
- 1 April 1998
- Published by Springer Nature in Pediatric Research
- Vol. 43 (4) , 296
Does early closure of PDA with ibuprofen reduce the severity of RDS in premature infants? † 1736
- 1 April 1998
- Published by Springer Nature in Pediatric Research
- Vol. 43 (4) , 296
Does early closure of PDA with ibuprofen reduce the severity of RDS in premature infants? † 1736